Proposed Acquisition, Placing, Broker Option, Rule 9 Waiver, Share Restructuring and Notice of General Meeting

IXICO today announces that it has entered into an Acquisition Agreement to conditionally acquire the entire issued share capital of Optimal Medicine in consideration for the issue of up to £1.5 million in Consideration Shares at an effective issue price of 49 pence per share (a 53.1 per cent. premium to the closing mid-market price of 32 pence on 17 November 2015, being the last dealing day prior to announcement of the Proposals). The Company is also proposing to raise approximately £2.7 million before expenses by way of a conditional placing at the Placing Price of 30.5p per share.

By |2017-10-10T16:40:10+00:0018 November 2015|Financial|